193 related articles for article (PubMed ID: 36614035)
1. HMGA1 Regulates the Expression of Replication-Dependent Histone Genes and Cell-Cycle in Breast Cancer Cells.
Petrosino S; Pacor S; Pegoraro S; Gazziero VA; Canarutto G; Piazza S; Manfioletti G; Sgarra R
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614035
[TBL] [Abstract][Full Text] [Related]
2. HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1.
Zanin R; Pegoraro S; Ros G; Ciani Y; Piazza S; Bossi F; Bulla R; Zennaro C; Tonon F; Lazarevic D; Stupka E; Sgarra R; Manfioletti G
J Exp Clin Cancer Res; 2019 Jul; 38(1):313. PubMed ID: 31311575
[TBL] [Abstract][Full Text] [Related]
3. HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel.
Sgubin M; Pegoraro S; Pellarin I; Ros G; Sgarra R; Piazza S; Baldassarre G; Belletti B; Manfioletti G
Cell Death Dis; 2022 May; 13(5):429. PubMed ID: 35504904
[TBL] [Abstract][Full Text] [Related]
4. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
[TBL] [Abstract][Full Text] [Related]
5. AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers.
Tolza C; Bejjani F; Evanno E; Mahfoud S; Moquet-Torcy G; Gostan T; Maqbool MA; Kirsh O; Piechaczyk M; Jariel-Encontre I
Mol Cancer Res; 2019 Oct; 17(10):1999-2014. PubMed ID: 31300541
[TBL] [Abstract][Full Text] [Related]
6. Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
Méndez O; Peg V; Salvans C; Pujals M; Fernández Y; Abasolo I; Pérez J; Matres A; Valeri M; Gregori J; Villarreal L; Schwartz S; Ramon Y Cajal S; Tabernero J; Cortés J; Arribas J; Villanueva J
Clin Cancer Res; 2018 Dec; 24(24):6367-6382. PubMed ID: 30135148
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Extracellular HMGA1 in Breast Cancer.
Méndez O; Pérez J; Soberino J; Racca F; Cortés J; Villanueva J
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779212
[TBL] [Abstract][Full Text] [Related]
8. Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes HMGA1, FOXM1, and MYBL2 in triple-negative breast cancer.
Fiscon G; Pegoraro S; Conte F; Manfioletti G; Paci P
FEBS Lett; 2021 Jun; 595(11):1569-1586. PubMed ID: 33835503
[TBL] [Abstract][Full Text] [Related]
9. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
[TBL] [Abstract][Full Text] [Related]
10. TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.
Xu X; Zhang L; He X; Zhang P; Sun C; Xu X; Lu Y; Li F
Biochem Biophys Res Commun; 2018 Jul; 502(1):160-165. PubMed ID: 29792857
[TBL] [Abstract][Full Text] [Related]
11. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
[TBL] [Abstract][Full Text] [Related]
12. HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation.
Brocher J; Vogel B; Hock R
BMC Cell Biol; 2010 Aug; 11():64. PubMed ID: 20701767
[TBL] [Abstract][Full Text] [Related]
13. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
[TBL] [Abstract][Full Text] [Related]
14. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
[TBL] [Abstract][Full Text] [Related]
15. HMGA1, Moonlighting Protein Function, and Cellular Real Estate: Location, Location, Location!
Pujals M; Resar L; Villanueva J
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572547
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.
Zhang Y; Ma T; Yang S; Xia M; Xu J; An H; Yang Y; Li S
Mol Cell Biochem; 2011 Nov; 357(1-2):363-71. PubMed ID: 21656127
[TBL] [Abstract][Full Text] [Related]
17. A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
Pegoraro S; Ros G; Ciani Y; Sgarra R; Piazza S; Manfioletti G
Oncotarget; 2015 Aug; 6(22):19087-101. PubMed ID: 26265440
[TBL] [Abstract][Full Text] [Related]
18. High mobility group A1 and cancer: potential biomarker and therapeutic target.
Shah SN; Resar LM
Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
[TBL] [Abstract][Full Text] [Related]
19. The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair.
Pellarin I; Arnoldo L; Costantini S; Pegoraro S; Ros G; Penzo C; Triolo G; Demarchi F; Sgarra R; Vindigni A; Manfioletti G
PLoS One; 2016; 11(10):e0164258. PubMed ID: 27723831
[TBL] [Abstract][Full Text] [Related]
20. High mobility group protein HMGA1 inhibits retinoblastoma protein-mediated cellular G0 arrest.
Ueda Y; Watanabe S; Tei S; Saitoh N; Kuratsu J; Nakao M
Cancer Sci; 2007 Dec; 98(12):1893-901. PubMed ID: 17877762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
